A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention

Authors

Institutions

Publication Details

Journal
The Journal of Headache and Pain
Published
2025-12-09
DOI
https://doi.org/10.1186/s10194-025-02225-7
Citations
1
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention

Esther Straghan, Nick G. Vatakis, Robert J. Fountaine, Sergey Dubrovin et al.
1 citations
The Journal of Headache and Pain
Migraine and Headache Studies
1.47
article

A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention

Esther Straghan, Nick G. Vatakis, Robert J. Fountaine, Sergey Dubrovin, Terence Fullerton, Jeremias Antinew, Vittorio Loprinzo, Patrizia DeBesi
article en
1 citations

Abstract

No abstract available for this paper.
The Journal of Headache and PainVol. 27(1)
Pfizer (United States) (US), Pfizer (United Kingdom) (GB), Pfizer (France) (FR), Coney Island Hospital (US), Pfizer (Italy) (IT)
Openalex Percentile: Top 13%
Migraine and Headache Studies
1.47
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention — Esther Straghan, Nick G. Vatakis, et al. · The Journal of Headache and Pain (2025) | TGRS Research Map | TGRS